FULL PAPER
tetra-n-butylammonium hydroxide solution (0.87 mL, 0.87 mmol)
and 2e (200 mg, 0.29 mmol), yield 120 mg (0.16 mmol, 55%).
HPLC: 5.6 min, 95.0%. 1H NMR (600.1 MHz, [D6]dmso): δ =
[InIII{dtpa-N,NЈЈ-bis(o-ethoxyphenylamide)}] (4b): Prepared follow-
ing procedure B from InIII chloride (52 mg, 0.24 mmol) and 2b
(150 mg, 0.24 mmol). Purification by column chromatography (sil-
10.26 (s, 1 H, NH-CO), 10.14 (s, 1 H, NH-CO), 7.51–7.46 (m, 4 H, ica, MeOH/H2O, 2:1) followed by flash chromatography (silica,
HAr), 6.86 (m, H, HAr), 4.02–2.84 (m, 18 H, CH2CO, MeOH), yield 36 mg (0.05 mmol, 20%). HPLC: 4.2 min, 95.6%.
NCH2CH2N), 3.90 (t, JH,H = 6.5 Hz, 4H OCH2CH2CH2CH3), 1H NMR (400.1 MHz, [D4]MeOH): δ = 8.01–7.80 (m, 2 H, HAr),
1.68–1.62 (m, H, OCH2CH2CH2CH3), 1.41 (m, H, 7.42–6.77 (m, H, HAr), 4.15–2.89 (m, 22 H, CH2C=O,
4
3
4
4
6
OCH2CH2CH2CH3), 0.91 (m, 6 H, OCH2CH2CH2CH3) ppm. NCH2CH2N, OCH2CH3), 1.44–1.39 (m, 6 H, OCH2CH3) ppm.
13C{1H} NMR (100.6 MHz, [D6]dmso): δ = 170.7 (C=O), 170.6 13C{1H} NMR (100.6 MHz, [D4]MeOH): δ = 175.8 (C=O), 175.6
(C=O), 170.3 (C=O), 165.8 (C=O), 165.3 (C=O), 155.0 (O-CAr),
(C=O), 172.1 (C=O), 169.1 (C=O), 152.0 (O-CAr), 151.5 (O-CAr),
154.9 (O-CAr), 131.5 (N-CAr), 120.9 (CAr), 120.8 (CAr), 114.5 (CAr), 128.7 (N-CAr, CAr), 127.3 (N-CAr, CAr), 127.2 (N-CAr, CAr), 125.9
67.3 (OCH2CH2CH2CH3), 61.3 (CH2C=O, NCH2CH2N), 60.2 (N-CAr, CAr), 125.6 (N-CAr, CAr), 124.7 (N-CAr, CAr), 121.7 (CAr),
(CH2C=O, NCH2CH2N), 56.7 (CH2C=O, NCH2CH2N), 54.7 121.4 (CAr), 113.3 (CAr), 113.1 (CAr), 65.5 (OCH2CH3), 65.4
(CH2C=O, NCH2CH2N), 51.7 (CH2C=O, NCH2CH2N), 30.8 (OCH2CH3), 61.7 (CH2C=O, NCH2CH2N), 60.9 (CH2C=O,
(OCH2CH2CH2CH3),
(OCH2CH2CH2CH3) ppm. MS (ESI,
[M(71Ga)]+ 755, [M(69Ga)]+ 753; found m/z (%) = 755 (29)
18.8
(OCH2CH2CH2CH3),
13.8 NCH2CH2N), 58.1 (CH2C=O, NCH2CH2N), 57.2 (CH2C=O,
–
mode): calcd. for
NCH2CH2N), 56.3 (CH2C=O, NCH2CH2N), 53.1 (CH2C=O,
NCH2CH2N), 15.1 (OCH2CH3), 15.0 (OCH2CH3) ppm. MS (ESI,
[M(71Ga) + 1 – H]–, 754 (76) [M(71Ga) – H]–, 753 (40) [M(69Ga) + + mode): calcd. for [M(115In)]+ 743, [M(113In)]+ 741; found m/z (%)
1 – H]–, 752 (100) [M(69Ga) – H]–. C34H46GaN5O10·2H2O (790.50): = 767 (34) [M(115In) + 1 + Na]+, 766 (100) [M(115In) + Na]+, 764
calcd. C 51.66, H 6.38, N 8.86; found C 51.46, H 6.08, N 8.68.
(5) [M(113In) + Na]+. C30H38InN5O10·3.5H2O (806.52): calcd. C
44.68, H 5.62, N 8.68; found C 44.30, H 5.16, N 8.41.
General Procedure for the Preparation of the InIII and LuIII Com-
plexes 4a–e and 5a–e: dtpa-N,NЈЈ-bis(alkoxyphenyl)amide 2a–d
(1 equiv.) was dissolved or, in the case of 2e, suspended in hot water,
cooled to room temperature and an aqueous solution of InIII chlor-
ide (1 equiv.) or LuIII chloride hexahydrate (1 equiv.) was added,
respectively. The pH of the mixture was raised to 7.5 by the drop-
wise addition of 2.0 m NaOH solution. The solution was stirred at
room temperature overnight and the solvent was evaporated.
[InIII{dtpa-N,NЈЈ-bis(m-ethoxyphenylamide)}] (4c): Prepared follow-
ing procedure A from InIII chloride (122 mg, 0.55 mmol) and 2c
(350 mg, 0.55 mmol), yield 230 g (0.31 mmol, 55%). HPLC:
4.5 min, 98.8%. 1H NMR (600.1 MHz, [D6]dmso, 25 °C): δ = 11.44
(s, 1 H, NH-CO), 10.31 (s, 1 H, NH-CO), 7.54 (s, 1 H, HAr), 7.31–
7.27 (m, 2 H, HAr), 7.18 (m, 1 H, HAr), 7.12–7.10 (m, 2 H, HAr),
3
4
3
6.77 (dd, JH,H = 8.2, JH,H = 1.7 Hz, 1 H, HAr), 6.62 (dd, JH,H
=
4
8.2, JH,H = 1.7 Hz, 1 H, HAr), 4.10–2.61 (m, 22 H, CH2C=O,
NCH2CH2N, OCH2CH3), 1.35–1.30 (m, 6 H, OCH2CH3) ppm. 1H
NMR (600.1 MHz, [D6]dmso, 85 °C): δ = 10.11 (s, 0.3 H, NH-CO),
7.48 (s, 0.5 H, HAr), 7.33–7.09 (m, 5.5 H, HAr), 6.77 (s, 1 H, HAr),
6.65 (s, 1 H, HAr), 4.13–2.39 (m, 22 H, CH2C=O, NCH2CH2N,
OCH2CH3), 1.38–1.31 (m, 6 H, OCH2CH3) ppm. 13C{1H} NMR
(150.9 MHz, [D6]dmso): δ = 171.4 (C=O), 171.2 (C=O), 170.5,
(C=O) 170.4 (C=O), 166.9, 158.9 (O-CAr), 158.7 (O-CAr), 139.7 (N-
CAr), 138.0 (N-CAr), 129.7 (CAr), 129.5 (CAr), 112.3 (CAr), 111.8
(CAr), 111.6 (CAr), 109.7 (CAr), 106.6 (CAr), 105.6 (CAr), 63.3
(OCH2CH3), 62.9 (OCH2CH3), 60.8 (CH2C=O, NCH2CH2N), 60.0
(CH2C=O, NCH2CH2N), 59.6 (CH2C=O, NCH2CH2N), 56.2
(CH2C=O, NCH2CH2N), 55.3 (CH2C=O, NCH2CH2N), 55.1
(CH2C=O, NCH2CH2N), 54.5 (CH2C=O, NCH2CH2N), 52.0
(CH2C=O, NCH2CH2N), 50.5 (CH2C=O, NCH2CH2N), 14.6
(OCH2CH3), 14.5 (OCH2CH3) ppm. MS (ESI, + mode): calcd. for
[M(115In)]+ 743, [M(113In)]+ 741; found m/z (%) = 767 (34)
[M(115In) + 1 + Na]+, 766 (100) [M(115In) + Na]+, 764 (5) [M(113In)
+ Na]+, 744 (115) [M(115In) + H]+. C30H38InN5O10·H2O (761.57):
calcd. C 47.32, H 5.29, N 9.20; found C 47.52, H 5.06, N 9.20.
Procedure A: The residue was suspended in deionized water and
washed thoroughly with water to remove all traces of soluble inor-
ganic salts. The colourless solids were dried in vacuo.
Procedure B: The complexes with a higher solubility in water were
redissolved in a small amount of hot methanol and purified by
silica column chromatography. The colourless solids were dried in
vacuo.
[InIII{dtpa-N,NЈЈ-bis(m-methoxyphenylamide)}] (4a): Prepared fol-
lowing procedure B from InIII chloride (127 mg, 0.58 mmol) and
2a (350 mg, 0.58 mmol). Purification by column chromatography
(silica, MeOH/H2O, 1:1), yield 100 mg (0.14 mmol, 24%). HPLC:
1
4.2 min, 99.0%. H NMR (400.1 MHz, [D4]MeOH): δ = 7.38–6.58
(m, 8 H, HAr), 4.12–2.78 (m, 24 H, CH2C=O, NCH2CH2N,
OCH3) ppm. 13C{1H} NMR (100.6 MHz, [D4]MeOH): δ = 177.0
(C=O), 176.5 (C=O), 176.0 (C=O), 175.9 (C=O), 175.8 (C=O),
175.7 (C=O), 175.5 (C=O), 175.4 (C=O), 170.3 (C=O), 168.5
(C=O), 161.6 (O-CAr), 161.5 (O-CAr), 161.4 (O-CAr), 140.3 (N-
CAr), 140.2 (N-CAr), 130.9 (CAr), 130.8 (CAr), 130.6 (CAr), 114.4
(CAr), 113.7 (CAr), 113.5 (CAr), 113.4 (CAr), 113.1 (CAr), 111.2
(CAr), 111.1 (CAr), 110.9 (CAr), 107.9 (CAr), 107.3 (CAr), 107.2
[InIII{dtpa-N,NЈЈ-bis(p-ethoxyphenylamide)}] (4d): Prepared follow-
(CAr), 106.7 (CAr), 63.5 (CH2C=O, NCH2CH2N), 62.3 (CH2C=O, ing procedure A from InIII chloride (127 mg, 0.58 mmol) and 2d
NCH2CH2N), 61.6 (CH2C=O, NCH2CH2N), 61.1 (CH2C=O, (350 mg, 0.58 mmol), yield 168 mg (0.23 mmol, 39%). HPLC:
1
NCH2CH2N), 60.7 (CH2C=O, NCH2CH2N), 60.3 (CH2C=O, 4.7 min, 96.7%. H NMR (600.1 MHz, [D6]dmso): δ = 11.47 (s, 1
3
NCH2CH2N), 59.8 (CH2C=O, NCH2CH2N), 59.6 (CH2C=O, H, NH-CO), 10.22 (s, 1 H, NH-CO), 7.59 (d, JH,H = 7.5 Hz, 2 H,
3
3
NCH2CH2N), 57.9 (CH2C=O, NCH2CH2N), 57.6 (CH2C=O, HAr), 7.50 (d, JH,H = 8.9 Hz, 2 H, HAr), 6.96 (d, JH,H = 8.9 Hz,
3
NCH2CH2N), 57.2 (CH2C=O, NCH2CH2N), 57.1 (CH2C=O, 2 H, HAr), 6.86 (d, JH,H = 8.9 Hz, 2 H, HAr), 4.03–2.66 (m, 22 H,
NCH2CH2N), 57.0 (CH2C=O, NCH2CH2N), 56.7 (CH2C=O, CH2C=O, NCH2CH2N, OCH2CH3), 1.32–1.28 (m,
6
H,
NCH2CH2N), 56.3 (CH2C=O, NCH2CH2N), 55.8–55.7 OCH2CH3) ppm. 13C{1H} NMR (150.9 MHz, [D6]dmso): δ =
(OCH3) ppm. MS (ESI, + mode): calcd. for [M(115In)]+ 715, 171.4 (C=O), 171.1 (C=O), 170.7 (C=O), 196.3 (C=O), 166.3
[M(113In)]+ 713; found m/z (%) = 739 (34) [M(115In) + 1 + Na]+,
738 (100) [M(115In) Na]+, 736 (5) [M(113In) Na]+.
(C=O), 164.8 (C=O), 156.0 (O-CAr), 154.7 (O-CAr), 131.6 (N-CAr),
129.8 (N-CAr), 122.0 (CAr), 120.9 (CAr), 114.6 (CAr), 114.3 (CAr),
+
+
C28H34InN5O10·H2O·0.5CH3OH (749.45): calcd. C 45.67, H 5.11, 62.2 (OCH2CH3), 63.1 (OCH2CH3), 60.6 (CH2C=O, NCH2CH2N),
N 9.34; found C 45.94, H 4.88, N 9.03. The content of methanol
was established from its X-ray structure.
59.9 (CH2C=O, NCH2CH2N), 59.5 (CH2C=O, NCH2CH2N), 56.3
(CH2C=O, NCH2CH2N), 55.2 (CH2C=O, NCH2CH2N), 55.1
Eur. J. Inorg. Chem. 2015, 4125–4137
4135
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim